First-line Treatment Clinical Trials

20 clinical trials for First-line Treatment across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer — RECRUITING · PHASE1
• Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1) — RECRUITING · PHASE2
• Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients — RECRUITING · PHASE2
• Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases — RECRUITING · PHASE1
• Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care — RECRUITING
• Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial — RECRUITING · PHASE3
• SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL) — NOT_YET_RECRUITING · PHASE1
• A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma — COMPLETED · PHASE2
• A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE1
• Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial — NOT_YET_RECRUITING · PHASE2
• Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC) — COMPLETED · PHASE2
• Exercise in Patients With Advanced Non-small Cell Lung Cancer — NOT_YET_RECRUITING · NA
• Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma — OTHER · PHASE2
• Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma — OTHER · PHASE2
• Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients — OTHER · PHASE1
• Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC — OTHER · PHASE2
• Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC — OTHER · PHASE1
• Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer — COMPLETED
• POSITIVE - Study (Part III) Heidelberg — COMPLETED · NA

Refine this search